Hepatocellular Research Registry

Hepatocytes Clinical Trial

Official title:

CellzDirect: Hepatocellular Research Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00178893
• Other study ID #: 040220
• Status: Recruiting
• Start date: April 2004
• Est. completion date: December 2022

Study information

• Verified date: September 2018
• Source: Vanderbilt University Medical Center
• Contact: Carla M Ramsey, RN, BSN
• Phone: 615-936-0834
• Email: carla.thomas[@]Vanderbilt.edu
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is a registry of human hepatocytes (liver cells) for research purposes.

Description:

Patients scheduled for partial hepatectomy/liver surgery are asked permission to use their discarded liver tissue for purposes of studying:

1. how drugs/medicines affect the liver and

2. the effects of storing liver cells in the cold or freezing.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: December 2022
• Est. primary completion date: December 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Persons undergoing partial hepatectomy/liver surgery for any reason.

Exclusion Criteria:

• Persons with known HIV, hepatitis B virus (HBV), or hepatitis C virus (HCV)

• A diagnosis of hepatocellular carcinoma without negative serologies

• A diagnosis of cholangiocarcinoma, where the total bilirubin has ever been greater or equal to 3.0

• The presence of a biliary drainage tube

• Active sepsis

Related Conditions & MeSH terms

• Hepatocytes

Locations

Country	Name	City	State
United States	Vanderbilt University	Nashville	Tennessee

Sponsors (1)

Lead Sponsor	Collaborator
Vanderbilt University

Country where clinical trial is conducted

United States,